Owkin Teams Up with AWS to Advance Generative AI for Precision Medicine
admin@pathologynews.com2024-02-08T12:37:02+00:00Today, Owkin, a TechBio that combines the best of human and artificial intelligence to find the right treatment for every patient, announced it is working with Amazon Web Services (AWS) to transform drug discovery, de-risk and accelerate clinical trials, and develop AI diagnostics. Owkin will leverage AWS’s proven global infrastructure and secure, extensive and reliable cloud platform to enhance data operations, optimize for operational excellence, and drive forward research in precision medicine.











